A cluster randomised controlled trial of a ward-based intervention to improve access to psychologically-informed care and psychological therapy for mental health in-patients.

Acute mental health Cluster trial Health economic analysis Inpatient Process evaluation Psychological therapy

Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
03 02 2022
Historique:
received: 26 11 2021
accepted: 09 01 2022
entrez: 4 2 2022
pubmed: 5 2 2022
medline: 12 4 2022
Statut: epublish

Résumé

There is good evidence that psychological interventions improve patient well-being and independent living, but patients on acute mental health wards often do not have access to evidence-based psychological therapies which are strongly advised by NICE guidance for severe mental health problems. The overall aim of this programme of work is to increase patient access to psychological therapies on acute mental health inpatient wards. Stage one of the programme (which is complete) aimed to identify barriers and facilitators to delivering therapy in these settings through a large qualitative study. The key output of stage one was an intervention protocol that is designed to be delivered on acute wards to increase patient access to psychologically-informed care and therapy. Stage two of the programme aims to test the effects of the intervention on patient wellbeing and serious incidents on the ward (primary outcomes), patient social functioning and symptoms, staff burnout, ward atmosphere from staff and patient perspectives and cost effectiveness of the intervention (secondary outcomes). The study is a single blind, pragmatic, cluster randomised controlled trial and will recruit thirty-four wards across England that will be randomised to receive the new intervention plus treatment as usual, or treatment as usual only. Primary and secondary outcomes will be assessed at baseline and 6-month and 9-month follow-ups, with serious incidents on the ward collected at an additional 3-month follow-up. The key output will be a potentially effective and cost-effective ward-based psychological intervention that increases patient access to psychological therapy in inpatient settings, is feasible to deliver in inpatient settings and is acceptable to patients. ClinicalTrials.gov Identifier: NCT03950388. Registered 15

Sections du résumé

BACKGROUND
There is good evidence that psychological interventions improve patient well-being and independent living, but patients on acute mental health wards often do not have access to evidence-based psychological therapies which are strongly advised by NICE guidance for severe mental health problems. The overall aim of this programme of work is to increase patient access to psychological therapies on acute mental health inpatient wards. Stage one of the programme (which is complete) aimed to identify barriers and facilitators to delivering therapy in these settings through a large qualitative study. The key output of stage one was an intervention protocol that is designed to be delivered on acute wards to increase patient access to psychologically-informed care and therapy. Stage two of the programme aims to test the effects of the intervention on patient wellbeing and serious incidents on the ward (primary outcomes), patient social functioning and symptoms, staff burnout, ward atmosphere from staff and patient perspectives and cost effectiveness of the intervention (secondary outcomes).
METHODS
The study is a single blind, pragmatic, cluster randomised controlled trial and will recruit thirty-four wards across England that will be randomised to receive the new intervention plus treatment as usual, or treatment as usual only. Primary and secondary outcomes will be assessed at baseline and 6-month and 9-month follow-ups, with serious incidents on the ward collected at an additional 3-month follow-up.
DISCUSSION
The key output will be a potentially effective and cost-effective ward-based psychological intervention that increases patient access to psychological therapy in inpatient settings, is feasible to deliver in inpatient settings and is acceptable to patients.
TRIAL REGISTRATION NUMBER
ClinicalTrials.gov Identifier: NCT03950388. Registered 15

Identifiants

pubmed: 35114980
doi: 10.1186/s12888-022-03696-7
pii: 10.1186/s12888-022-03696-7
pmc: PMC8815159
doi:

Banques de données

ClinicalTrials.gov
['NCT03950388']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

82

Informations de copyright

© 2022. The Author(s).

Références

Br J Psychiatry. 2009 Feb;194(2):152-7
pubmed: 19182178
BMC Psychiatry. 2012 Nov 21;12:204
pubmed: 23171304
Int J Nurs Stud. 2015 Sep;52(9):1412-22
pubmed: 26166187
Int J Nurs Stud. 2012 Nov;49(11):1403-10
pubmed: 22789460
Epidemiol Psychiatr Sci. 2012 Dec;21(4):393-9
pubmed: 22793652
Br J Psychiatry. 2018 Aug;213(2):490-497
pubmed: 29941055
J Ment Health. 2011 Aug;20(4):336-46
pubmed: 21770782
Clin Psychol Psychother. 2021 Nov;28(6):1587-1597
pubmed: 33843107
Adm Policy Ment Health. 2012 Sep;39(5):341-52
pubmed: 21533847
Implement Sci. 2012 Mar 22;7:23
pubmed: 22436121
J Ment Health. 2021 Feb;30(1):43-50
pubmed: 31070070
Int J Nurs Stud. 2021 Mar;115:103870
pubmed: 33486388
Br J Clin Psychol. 2016 Sep;55(3):236-52
pubmed: 25884235
Schizophr Bull. 2008 May;34(3):523-37
pubmed: 17962231
Harv Rev Psychiatry. 2005 Jul-Aug;13(4):206-17
pubmed: 16126607
J Clin Psychol. 2017 Oct;73(10):1211-1225
pubmed: 28026872
Trials. 2016 Feb 11;17:79
pubmed: 26869076
J Ment Health. 2012 Feb;21(1):57-71
pubmed: 22257131
Acta Psychiatr Scand. 2000 Apr;101(4):323-9
pubmed: 10782554
Psychiatry Res. 2011 Jan 30;185(1-2):261-8
pubmed: 20537717
BMC Psychiatry. 2015 Mar 04;15:35
pubmed: 25881240

Auteurs

Katherine Berry (K)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, Manchester, UK. katherine.berry@manchester.ac.uk.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK. katherine.berry@manchester.ac.uk.

Jessica Raphael (J)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, Manchester, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Helen Wilson (H)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, Manchester, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Sandra Bucci (S)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, Manchester, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Richard J Drake (RJ)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, Manchester, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Dawn Edge (D)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, Manchester, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Richard Emsley (R)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Gill Gilworth (G)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, Manchester, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Karina Lovell (K)

Division of Nursing, Midwifery and Social Work, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Bolanle Odebiyi (B)

Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Owen Price (O)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Matt Sutton (M)

Division of Population Health, Health Services Research & Primary Care, The University of Manchester, Manchester, UK.

Rachel Winter (R)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, Manchester, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Gillian Haddock (G)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, Manchester, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH